Vinod Ravi

Associate Professor

  • 1199 Citations
  • 17 h-Index
20052019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Vinod Ravi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 10 Similar Profiles
Sarcoma Medicine & Life Sciences
Hemangiosarcoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Survival Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Doxorubicin Medicine & Life Sciences
Heart Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2005 2019

3 Citations (Scopus)

Alpha particle radium 223 dichloride in high-risk osteosarcoma: A phase i dose escalation trial

Subbiah, V., Anderson, P. M., Kairemo, K., Hess, K., Huh, W. W., Ravi, V., Daw, N. C., Somaiah, N., Ludwig, J. A., Benjamin, R. S., Chawla, S., Hong, D. S., Meric-Bernstam, F., Ravizzini, G., Kleinerman, E., Macapinlac, H. & Rohren, E., Jan 1 2019, In : Clinical Cancer Research. 25, 13, p. 3802-3810 9 p.

Research output: Contribution to journalArticle

Open Access
Alpha Particles
Radium
Osteosarcoma
Neoplasm Metastasis
Technetium Tc 99m Medronate

Dendritic cell vaccination plus low-dose doxorubicin for the treatment of spontaneous canine hemangiosarcoma

Konduri, V., Halpert, M. M., Baig, Y. C., Coronado, R., Rodgers, J. R., Levitt, J. M., Cerroni, B., Piscoya, S., Wilson, N., DiBernardi, L., Omarbekov, Z., Seelhoff, L., Ravi, V., Douglass, L. & Decker, W. K., Sep 1 2019, In : Cancer gene therapy. 26, 9-10, p. 282-291 10 p.

Research output: Contribution to journalArticle

Open Access
Hemangiosarcoma
Doxorubicin
Dendritic Cells
Canidae
Vaccination

MAGE-A3 is a clinically relevant target in undifferentiated pleomorphic sarcoma/myxofibrosarcoma

Conley, A. P., Wang, W. L., Livingston, J. A., Ravi, V., Tsai, J. W., Ali, A., Ingram, D. R., Lowery, C. D., Roland, C. L., Somaiah, N., Hwu, P., Yee, C., Subbiah, V., Futreal, A., Lazar, A. J., Patel, S. & Roszik, J., May 2019, In : Cancers. 11, 5, 677.

Research output: Contribution to journalArticle

Open Access
Sarcoma
Immunotherapy
Neoplasms
Lymphocytes
Encyclopedias

Unique aberrations in intimal sarcoma identified by next-generation sequencing as potential therapy targets

Roszik, J., Khan, A., Conley, A. P., Livingston, J. A., Groisberg, R., Ravi, V., Pestana, R. C., Sen, S. & Subbiah, V., Sep 2019, In : Cancers. 11, 9, 1283.

Research output: Contribution to journalArticle

Open Access
Tunica Intima
Gene Fusion
Platelet-Derived Growth Factor beta Receptor
Sarcoma
Genomics
4 Citations (Scopus)

A multicenter phase II study of Q3 week or weekly paclitaxel in combination with bevacizumab for the treatment of metastatic or unresectable angiosarcoma

Bui, N., Kamat, N., Ravi, V., Chawla, S., Lohman, M. & Ganjoo, K. N., Jan 1 2018, In : Rare Tumors. 10

Research output: Contribution to journalArticle

Hemangiosarcoma
Paclitaxel
Safety
Disease-Free Survival
Therapeutics